Navigation Links
Multiple malaria infection inhibits spread of parasite

People who are frequently infected with malaria parasites can develop immunity against the gametocyte, the infectious stage. This immunity inhibits the spread of the parasite. Dutch researcher Mike van der Kolk discovered this during his research into malaria transmission under the inhabitants of Cameroon, Senegal and Indonesia. After just a few infections, people can develop immunity that inhibits transmission.

Malaria is not caused by a mosquito but by a parasite in the mosquito. The malaria parasite needs the mosquito to reproduce and spread. The gametocyte is the developmental stage of the parasite that can be transmitted from people to the mosquito. In the mosquito's stomach the gametes are released and fertilisation takes place. The parasite develops further until the final stage (the sporozoite) in the salivary gland. The sporozoite can be transmitted with the saliva to a person if he/she is bitten by this mosquito. There the parasite reproduces rapidly and the person becomes ill.

Immunity

People who live in areas where malaria is prevalent, can develop a natural immunity that stops the development of the parasite in the mosquito. This prevents the parasite from spreading further. The presence of this immunity, the so-called transmission-reducing activity, is determined using a laboratory test. Van der Kolk discovered that people who are often infected with malaria could quickly acquire this immunity. He also found that people with higher numbers of gametocytes are more frequently immune.

Infectious bites

Each year more than 200 million people develop malaria. More than one million people die from malaria each year. In Cameroon, the researchers recorded how often people were bitten by a mosquito that carried malaria parasites. They also examined the number of transmittable parasites in the blood of infected persons. In a neighbourhood of the capital Yaoundé, 34 infectious bites per person per yea
'"/>

Source:Netherlands Organization for Scientific Research


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Multiple Campylobacter Genomes Sequenced
3. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
4. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
5. OHSU researchers discover potential mechanism to repair brain damage linked to Multiple Sclerosis
6. Multiple genes permit closely related fish species to mix and match their color vision
7. Scientists reveal molecular secrets of the malaria parasite
8. Simple drug has the potential to save many lives threatened by malaria
9. Molecular models advance the fight against malaria
10. Reducing malarial transmission in Africa
11. Sickle cell and protection against malaria
Post Your Comments:
Breaking Biology News(10 mins):Self-destructing bacteria improve renewable biofuel production 2Self-destructing bacteria improve renewable biofuel production 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 1Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 2Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 3The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 1The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 2The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 3The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 4The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 5Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 1Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 2
Breaking Biology Technology:BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6